LACK OF VALUE FOR CISPLATIN ADDED TO MITOMYCIN-DOXORUBICIN COMBINATION CHEMOTHERAPY FOR CARCINOMA OF UNKNOWN PRIMARY SITE - A RANDOMIZED TRIAL

被引:48
作者
EAGAN, RT [1 ]
THERNEAU, TM [1 ]
RUBIN, J [1 ]
LONG, HJ [1 ]
SCHUTT, AJ [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV MED RES STAT,ROCHESTER,MN 55905
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 01期
关键词
D O I
10.1097/00000421-198702000-00018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:82 / 85
页数:4
相关论文
共 11 条
[1]   DIFFERING RESPONSE RATES AND SURVIVAL BETWEEN SQUAMOUS AND NON-SQUAMOUS NON-SMALL CELL LUNG-CANCER - COMPARISON OF CAP VERSUS MAP [J].
EAGAN, RT ;
FRYTAK, S ;
CREAGAN, ET ;
RICHARDSON, RL ;
COLES, DT ;
JETT, JR .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (03) :249-254
[2]  
EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[3]  
2-4
[4]  
EDMONSON JH, 1985, CANCER CHEMOTH PHARM, V15, P181
[5]  
ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147
[6]   5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN IN THE TREATMENT OF ADENOCARCINOMA OF UNKNOWN PRIMARY [J].
GOLDBERG, RM ;
SMITH, FP ;
UENO, W ;
AHLGREN, JD ;
SCHEIN, PS .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :395-399
[7]   DRUGS 5 YEARS LATER - CISPLATIN [J].
LOEHRER, PJ ;
EINHORN, LH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :704-713
[8]  
MOERTEL CG, 1972, CANCER-AM CANCER SOC, V30, P1469, DOI 10.1002/1097-0142(197212)30:6<1469::AID-CNCR2820300609>3.0.CO
[9]  
2-T
[10]   ADENOCARCINOMA OF UNKNOWN PRIMARY SITE - CLINICOPATHOLOGICAL STUDY [J].
SNYDER, RD ;
MAVLIGIT, GM ;
VALDIVIESO, M .
MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 6 (04) :289-294